Re: Predictors of infectious complications after targeted prophylaxis for prostate needle biopsy

File Description SizeFormat 
Word of Wisdom - EU- HUA-24-03-2018.docxFile embargoed until 21 April 2019156.06 kBMicrosoft Word    Request a copy
Title: Re: Predictors of infectious complications after targeted prophylaxis for prostate needle biopsy
Author(s): Miah, S
Winkler, M
Ahmed, HU
Item Type: Journal Article
Abstract: Papagiannopoulos D, Abern M, Wilson N, et alJ Urol 2018;199:155–60Experts’ summary:Papagiannopoulos et al [1] are to be congratulated on their reporting of over 5000 men undergoing transrectal ultrasound-guided (TRUS) prostate biopsy with targeted antimicrobial prophylaxis with preprocedure rectal swab cultures. This method led to an overall infectious complication rate of 1.1%, whilst it was 3.9% for those harbouring a fluoroquinolone-resistant organism (odds ratio 9.98). Their article concluded that one should consider using alternative biopsy approaches to minimise infectious complications in this higher-risk cohort who harbour fluoroquinolone resistance.
Publication Date: 21-Apr-2018
Date of Acceptance: 7-Apr-2018
URI: http://hdl.handle.net/10044/1/58965
DOI: https://dx.doi.org/10.1016/j.eururo.2018.04.007
ISSN: 0302-2838
Publisher: Elsevier
Journal / Book Title: European Urology
Copyright Statement: © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor/Funder: Wellcome Trust
University College London Hospitals Charity
Funder's Grant Number: 204998/Z/16/Z
1348
Keywords: 1103 Clinical Sciences
Urology & Nephrology
Publication Status: Published online
Conference Place: Switzerland
Embargo Date: 2019-04-21
Online Publication Date: 2018-04-21
Appears in Collections:Division of Surgery
Faculty of Medicine



Items in Spiral are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons